Clinical Trial: A Single-Center, Single-Arm Clinical Study on the Efficacy and Safety of Neoadjuvant Therapy with Paclitaxel Polymer Micelle Injection Combined with Gemcitabine in Locally Advanced Pancreatic Cancer Without Distant Metastasis (China)

China, Oct. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-Center, Single-Arm Clinical Study on the Efficacy and Safety of Neoadjuvant Therapy with Paclitaxel Polymer Micelle Injection Combined with Gemcitabine in Locally Advanced Pancreatic Cancer Without Distant Metastasis'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600134825

Registration Time: 2026/10/21

Type: Interventional study

Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347102

Published by HT Digital Content Services with permission from Health Daily Digest...